FDA authorizes first COVID test via traditional review pathway

FDA authorizes first COVID test via traditional review pathway

Source: 
RAPS.org
snippet: 

The US Food and Drug Administration (FDA) on Wednesday authorized the first diagnostic for COVID-19 using a traditional review process, paving the way for more tests to gain clearance through the agency’s 510(k) pathway.